Cargando…
The influence of Sm-153 therapy on bone marrow function
AIM OF THE STUDY: Studies about possible risks connected with β-emitterradiotherapy concentrate mainly on potential myelotoxicity. Results of previously published analysis based on white blood cells (WBC) and platelet (PLT) counts – before and after radionuclide treatment – are quite varied. The aim...
Autores principales: | Małkowski, Bogdan, Maruszak, Marta, Dudek, Anna, Wędrowski, Mateusz, Szefer, Jarosław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371705/ https://www.ncbi.nlm.nih.gov/pubmed/28373820 http://dx.doi.org/10.5114/wo.2016.64598 |
Ejemplares similares
-
FDG PET/CT as a survival prognostic factor in patients with advanced renal cell carcinoma
por: Pankowska, Violetta, et al.
Publicado: (2018) -
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [$^{153}$Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022) -
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [(153)Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022) -
Treatment efficacy of (153)Sm-EDTMP for painful bone metastasis
por: Ayati, Narjess, et al.
Publicado: (2013) -
Radionuclide Treatment with 153Sm-EDTMP is Effective for the Palliation of Bone Pain in the Context of Extensive Bone Marrow Metastases: A Case Report
por: Kairemo, Kalevi, et al.
Publicado: (2014)